市場調査報告書：バイオテクノロジー試薬とサプライの世界市場－戦略分析と将来予測－

Abstract

This report analyzes the worldwide markets for Reagents & Supplies in Biotechnology in Millions of US$. The specific product segments analyzed are Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Latin America. Annual forecasts are provided for each region and product segment for the period of 2000 through 2010. The report profiles 298 companies including many key and niche players worldwide such as Abbott Diagnostics, Applied Biosystems, Beckman Coulter, Inc., Becton Dickinson and Company, Biomerieux, Chemicon International, Inc.., Cortex Biochem, Inc., Dade Behring, EMD Biosciences, GE Healthcare, Invitrogen Corporation, Ortho-Clinical Diagnostics, Perkin Elmer, Inc., Promega Corporation, Roche Diagnostics, and Sigma -- Aldrich. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
Cell & Tissue Culture Reagents I-3
DNA Synthesis & Sequencing Reagents I-4
Electrophoresis Reagents I-4
Flow Cytometry Reagents I-4
Immunoassay Reagents I-4
Liquid Chromatography Reagents I-5
PCR Reagents I-5
Protein Synthesis & Sequencing Reagents I-5

II. EXECUTIVE SUMMARY

1. Outlook II-1

Analysis by Geographic Region II-1
Analysis by Product Segment II-1
Reagents Market Players Witnessing Paradigm Shift II-1

2. Market Dynamics II-2

Highly Automated Instrumentation Restricts Use of Reagents II-2
Software-Intensive Nature and High System Complexity Impedes Use of Automated Instruments II-2
Demand for Diverse Products Spurs Growth II-2
Increasing Use in Industrial Sector II-2
Molecular Biology and Protein Synthesis Reagents - the Fastest Growing Segments II-3
Obtaining Data from Enzyme Functions II-3
New Economy Sees the Entry of Directed Evolution Enzymes II-3

3. Biotechnology - Industry Overview II-4

Growing by Leaps and Bounds II-4
Human Genome Mapping - A Colossal Milestone II-4
High Growth Applications Spur Industry Growth II-5
Biochips- Promising Future II-5
Convergence of Distinct Technologies II-6
Growing Collaboration between Biotech and Pharma Companies II-6

4. Product Overview II-7

A. Classification II-7
i. DNA Synthesis & Sequencing Reagents II-7
DNA: The Basis for Modern Biotechnology II-7
ii. PCR Reagents II-7
iii. Protein Synthesis & Sequencing Reagents II-7
iv. Electrophoresis Reagents II-8
v. Bio/Chemiluminescence Reagents II-8
vi. Immunoassay Reagents II-8
Antibodies II-8
Monoclonal and Polyclonal Antibodies II-8
Types of Monoclonal Antibodies II-8
a. Murine Monoclonal Antibodies II-8
b. Human Antibodies II-9
c. Chimeric Antibodies II-9
d. Bispecific Antibodies II-9
Hematology/Coagulation Reagents II-9
vii. Chromatography Reagents II-9
viii. Flow Cytometry Reagents II-9
ix. Cell & Tissue Culture Reagents II-10

5. Product Innovations/Introductions II-11

Ortho-Clinical Diagnostics Launches VITROS® Chemistry Products d%A1c Reagent II-11
Beckman Coulter to Launch Access DHEA-S II-11
Solulink Introduces ChromaLink II-11
Cambrex Launches Versalinx Reagents II-11
Kreatech Unveils a New Range of Isolation and Labeling Kits II-11
Nanogen Launches Enterovirus Analyte Specific Reagent - MGB Alert™ II-11
Olympus Unveils New Reagent Kit with Single Molecular Fluorescence Spectroscopy II-12
SAFC Releases Proligo Reagents II-12
LI-COR Biosciences Releases New IRDye® Western Kits for Odyssey® System II-12
Altor Launches STAR™ Multimer Reagents II-12
Guava Technologies Launches a New Range of Antibody Reagents II-12
Solexa Launches Genome Analysis System II-12
Daiichi Unveils New Reagent Kit II-12
ReaMetrix Introduces Accuford II-13
TriPath Imaging Unveils ProEx C II-13
Roche and 454 Life Sciences Launches Genome Sequencer 20 System and Reagents II-13
Chinese Academy of Military Medical Sciences IntroducesReagent to Test Drug Resistance of HBV II-13
SIAL Unveils SYBR Green Extract-N-Amp Tissue PCR Kit II-13
Aldrich Introduces LAB Reagents II-13
Kreatech Rolls Out RNA ampULSe Amplification and Labeling Kits II-14
BioM&eacure;rieux Launches NucliSens miniMAG and NucliSens Magnetic Extraction Reagents II-14
Guava Technologies Launches a New Cell Cycle Assay II-14
U.S. Genomics Introduces Direct miRNA Reagents for Trilogy Platform II-14
Dharmacon Inc, Introduces siGENOME(TM) siRNA II-15
Agencourt Bioscience Introduces RNA Isolation and Purification Kit II-15
Caliper Life Sciences in Collaboration with Promega Offers Automation Protocols II-16
French Researchers Develop Novel Sandwich
Immunoassay for Small Molecule Study II-16
Do-Coop Technologies Launches Water-based Nano-Reagent II-16
Affymetrix Inc, Collaborates with Invitrogen to Launch Reagents for GeneChip II-16
Roche Unveils Amplicor HPV in the US II-17
Shimadzu Develops Reagent for Cell-Free Protein Synthesis II-17
Roche Working on PCR-based Linear Array Test for HPV II-17
Takara Bio Releases OmniMix HS II-17
Cortex Biochem Unveils MagaZorb RNA Mini-Prep Kit II-17
Invitrogen Launches cDNA Library Construction Kit II-18
PharmaDesign Develops New Reagents II-18
Tecan Systems Introduces DNA Extraction Kits II-18
Proligo Introduces TrueSNP Primer Kit II-18
Proligo Introduces TrueSNP Primer Kit II-18
Invitrogen Launches OligofectAMINE Reagent II-18
GeneMachines introduces New Line of OmniGrid Slides and Reagents II-18
Third Wave Introduces Four New Invader Clinical Reagents II-19
Mitsubishi Chemical, Wakenyaku and Toyobo Develop New Reagent II-19
Amersham Biosciences Launches Reagent Kit II-19
Beckman Coulter Unveils Ready-to-Use Histocompatibility Complex Tetramer Reagents II-20
Prolinx Unveils Proteomics Products II-20
Minerva Biolabs Launches Reagents and Diagnostic Kits II-20
Molecular Devices Corp Launches Reagent Kits II-20
Qiagen Releases ProofStart DNA Polymerase II-20
Pyrosequencing Launches Reagent Kits and Sequence Analysis Software II-21
Argonaut Technologies Launches Three Reagents II-21
Trevigen Introduces Antibodies, Kits & Reagents II-21
Link Technologies Launches Reagent Kit II-21
Argonaut Technologies Launches Organic Synthesis and Purification Accelerating Reagents II-21
Trevigen Inc., Introduces Antibodies, Kits And Reagents for Cell Death Study II-21
Amersham Pharmacia Launches DYEnamic ET terminator DNA Sequencing Kit II-21
Millipore Corp Launches Maestro Life Science Kits II-22

6. Recent Industry Activity II-23

Takara Bio. Pharma Acquires Stakes in Takara
Biotechnology II-23
Millipore Takes Over Serologicals II-23
Serologicals Takes Over LINCO II-23
Genospectra Merges with Panomics II-23
Roche Enters into Three-Year Contract with Premier II-23
KREATECH and GenTel Enter into Distribution Agreement II-24
Kreatech Enters into Supply Agreement with QIAGEN II-24
Invitrogen to Provide Reagents for Genome equencing of Solexa II-24
VWR International to Market Biocare Equipment and Reagents in IHC II-24
Biocare Partners with Epitomics for Reagents II-24
GE and CytoGenix Form an Alliance II-24
Fisher Biosciences Joins Forces with Dyomics II-24
PerkinElmer Partners with NCGC II-25
SAFC-Biosciences Formed to Support Sigma-Aldrich II-25
Takara Takes Over Clonetech II-25
Techne' s Subsidiary Pockets BiosPacific and Fortron Bio Science II-25
QIAGEN Obtains Nextal II-25
Invitrogen Takes Over Caltag II-26
Invitrogen Takes Over Biosource International II-26
Serologicals Acquires Specialty Media from Sentigen II-26
Invitrogen Acquires Zymed Laboratories II-26
Biotage Acquires Argonaut Technologies II-26
Invitrogen Acquires Dynal Biotech II-26
Vita and Cortex Biochem Enter into Distribution Agreement II-26
SIAL and OXB Sign an Agreement for CommercializingLentiVector Technology II-27
Funakoshi and Affibody Sign a Distribution Agreement II-27
KREATECH and GenTel Enter into Marketing Agreement II-27
KREATECH and Ambion Enter into Supply Agreement II-27
SIAL Enters into Distribution Agreement with MedAssets II-27
IBT Signs Distribution Contracts for Enzymes II-27
Epitome Signs a License Agreement with EMD Biosciences II-28
Consorta Inks Multiple Agreements with Dade Behring II-28
SCS and Chemicon Sign an Agreement for ES Cell Media II-28
LSBC and BioCatalytics Enter into Collaborative Agreement for Producing Enzymes II-28
Chemicon International Enters into an Agreement with QDC II-28
Dharmacon Signs an Agreement with Genentech II-29
Invitrogen Partners with PerkinElmer II-29
Chemicon and Axordia Collaborate for New Antibody Markers II-29
eGene Enters into Strategic Alliance with Transgenomic II-29
Cancer Genetics Selects Genetics Specialities II-29
Clinical Data Bags Distribution Rights for HematologyAnalyzers and Reagents II-30
BD Biosciences to Expand Production in Puerto Rico II-30
Olympus Enlarges R&D Unit in Ireland II-30
Olympus Begins Production of Immunoassay Reagents II-30
Koon-wah Leong, Shery Guo and Suyue Qian Produced Multilayer Test Strips II-30
CMT Sells off Specialty Media Division II-30
CSL Divests Cell Culture Reagent Business to Sigma-Aldrich II-30
Hycor Biomedical Merges with Stratagene Corporation II-31
GE Acquires Amersham plc II-31
CalbaTech Snaps Up K-D Medical II-31
Tepnel Life Sciences Acquires Diaclone Research SAS II-31
BD Acquires Atto Bioscience II-31
Invitrogen to Acquire Bio Asia II-32
Idexx Announce Plans to Acquire Switzerland-based Bommeli II-32
Chemicon Announce Plans to Acquire Product Lines from Primogenix II-32
Bio-Rad Laboratories to Acquire MJ GeneWorks II-33
D. Lansing Taylor Join Forces with PLSG to Create Cellumen II-33
eGene Inc. and Prisma Biotech form Distribution Alliance II-33
eGene Alliances with HVD Life Science and HVD Biotech Vertriebs-GmbH II-33
Cell Signaling Technology, Inc. and Zeptosens AG Sign Licensing Agreement for CST reagents II-34
Pierce and Tecan Enter into Drug Discovery Covenant II-34
Syntonix and Dyax Enter into Antibody Discovery Pact II-34
NeoPharm Signs an Agreement with Nippon Genetics II-35
Amersham Signs Distribution Agreement with Guava Technologies II-35
CST and LI-COR Sign an Agreement II-35
Cell Signaling Technology, Inc. Signs Agreement with ProQinase GmbH II-35
Sigma-Aldrich Signs a Distribution Agreement with Avecia II-36
LSBC and Sigma-Aldrich Enter into Recombinant Aprotinin Agreement II-36
Atugen Signs a Contract Research Agreement with Eisai II-36
CII Enters into Sub-License Agreement with Promega II-36
Dharmacon Signs Agreement with Wyeth Pharmaceuticals II-37
SurModics inks Distribution Agreement with SeraCare Life Sciences II-37
Hydra Biosciences Signs Agreement with Evotec OAI AG II-37
Chemicon International Strikes a Deal with Thromb-X N.V. II-37
Ambion Inks Agreement with Applied Biosystems II-38
Cosmo Bio Establishes New US Subsidiary II-38
Agilent Technologies Inc, Establishes Integrated Biology Solutions Unit II-38
BD Plans to Divest Clontech Business II-38
CeMines Completes Expansion Program II-38
Definiens AG Enters into an Agreement with SERVA Electrophoresis II-39
DNA Research Innovations Scrip Agreement with Tecan UK II-39
Perbio Acquires FBS Supplier in Australia II-39
Molecular Devices Consummates Acquisition of Argonex II-39
Perkin-Elmer Acquires Packard BioScience II-40
Invitrogen Acquires Dexter Corp and Life Science Technologies II-40
Luminex and Upstate Biotechnology Enter into Partnership II-40
Maxim Biotech Enters into Promotional Agreement with Agilent Technologies II-40
Luminex Forges Pact with Lifecodes II-40
BioInvent International Signs Agreement with Novo Nordisk II-41
Varian Acquires Liquid Chromatography Products From R&S Technology' s Line II-41
Luminex Grants Nonexclusive Rights to R&D Systems II-41
Visible Genetics Receives FDA Approval for TRUGENE HIV-1 Genotyping Kit II-41
Commonwealth Biotechnologies Receives Patent for AccuTrac II-41

7. Focus on Select Players Worldwide II-42

Abbott Diagnostics (US) II-42
Applied Biosystems (US) II-42
Beckman Coulter, Inc. (US) II-42
Becton Dickinson and Company (US) II-42
Biomerieux (France) II-43
Chemicon International, Inc. (US) II-43
Cortex Biochem Inc. (US) II-43
Dade Behring (US) II-43
EMD Biosciences (US) II-44
GE Healthcare (US) II-44
Invitrogen Corporation (US) II-44
Ortho-Clinical Diagnostics (US) II-45
PerkinElmer, Inc. (US) II-45
Promega Corporation (US) II-45
Roche Diagnostics (Switzerland) II-45
Sigma - Aldrich (US) II-46

8. Global Market Perspective II-47

Table 1: World Recent Past, Current & Future Market Analysis for Reagents in Biotechnology by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-47
Table 2: World 10-Year Perspective for Reagents in Biotechnology by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) II-47
Table 3: World Recent Past, Current & Future Market Analysis for Cell / Tissue Culture Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-48
Table 4: World 10-Year Perspective for Cell / Tissue Culture Reagents by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) II-48
Table 5: World Recent Past, Current & Future Market Analysis for DNA Sequencing / Synthesis Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-49
Table 6: World 10-Year Perspective for DNA Sequencing/Synthesis Reagents by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) II-49
Table 7: World Recent Past, Current & Future Market Analysis for Electrophoresis Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-50
Table 8: World 10-Year Perspective for Electrophoresis Reagents by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) II-50
Table 9: World Recent Past, Current & Future Market Analysis for Flow Cytometry Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-51
Table 10: World 10-Year Perspective for Flow Cytometry Reagents by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) II-51
Table 11: World Recent Past, Current & Future Market Analysis for Immunoassay Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-52
Table 12: World 10-Year Perspective for Immunoassay Reagents by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) II-52
Table 13: World Recent Past, Current & Future Market Analysis for Liquid Chromatography Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-53
Table 14: World 10-Year Perspective for Liquid Chromatography Reagents by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) II-53
Table 15: World Recent Past, Current & Future Market Analysis for Polymerase Chain Reaction Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-54
Table 16: World 10-Year Perspective for Polymerase Chain Reaction Reagents by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) II-54
Table 17: World Recent Past, Current & Future Market Analysis for Protein Synthesis Reagents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) II-55
Table 18: World 10-Year Perspective for Protein Synthesis Reagents by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Latin America Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) II-55

III. MARKET

1. United States III-1

A. Market Analysis III-1
Biotech Industry in the US III-1
Escalating Demand for Biomedical Research Reagents and Kits III-1
Application-Oriented Products Herald a Technological Upheaval III-2
Competition - Highly Prevalent III-2
Review of US Cell/Tissue Culture Supplies Market III-2
Industrial Segment -Largest End-User III-2
Rise in Cell Culture Equipment Demand Leads to Innovation III-3
Factors Influencing the Market for Media III-3
Fetal Bovine Serum - Use on a Decline III-3
Table 19: Leading Producers of Fetal Bovine Serum in the US (2004): Percentage Breakdown of Value Sales for Life Technologies, Hyclone, and Others (includes corresponding Graph/Chart) III-3Suppliers Searching for New Areas III-4Serum Free Products Market: Rapidly Growing III-4 Immunoassay Reagents III-4
Table 20: Leading Players in the US Immunoassay Reagents Market (2004): Percentage Breakdown of Value Sales for Abbott Diagnostics, Dade Behring, Roche Diagnostics, Beckman Coulter, and Others (includes corresponding Graph/Chart) III-4
Issues Affecting the US Immunodiagnostics Market III-5
Technological Innovations Play a Vital Role III-5
Molecular Biological Reagents III-5
Rapidly Growing Market III-5
Table 21: Molecular Biology Reagents Market in the US (2004): Percentage Breakdown of Value Sales by End use for Academic User, Biotech industry, Pharmaceuticals, and Government (includes corresponding Graph/Chart) III-5
DNA Sequencing: Gaining Prominence III-5
Key Players III-6
Abbott Diagnostics III-6
Applied Biosystems III-6
Beckman Coulter, Inc. III-6
Becton Dickinson and Company III-7
Chemicon International, Inc III-7
Cortex Biochem Inc. III-7
Dade Behring III-7
EMD Biosciences III-8
GE Healthcare III-8
Invitrogen Corporation III-8
Ortho-Clinical Diagnostics III-8
PerkinElmer, Inc III-8
Promega Corporation III-9
Sigma - Aldrich III-9
Product Launches III-9
Strategic Developments III-16
B. Market Analytics III-27
Table 22: US Recent Past, Current & Future Analysis for Reagents in Biotechnology by Product Segment - Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-27
Table 23: US 10-Year Perspective for Reagents in Biotechnology by Product Segment - Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-28

2. Canada III-29

A. Market Analysis III-29
Biotech Sector in Canada III-29
Outlook III-29
Biotech Reagents Market Overview III-29
Strategic Development III-29
B. Market Analytics III-30
Table 24: Canadian Recent Past, Current & Future Analysis for Reagents in Biotechnology by Product Segment - Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-30
Table 25: Canadian 10-Year Perspective for Reagents in Biotechnology by Product Segment - Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid ChromatographyReagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-31

3. Japan III-32

A. Market Analysis III-32
Biotech Scenario III-32
Outlook III-33
Product Launches III-33
Strategic Development III-34
B. Market Analytics III-36
Table 26: Japanese Recent Past, Current & Future
Analysis for Reagents in Biotechnology by Product Segment - Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently
Analyzed with Annual Sales Figures in US$ Million
for Years 2000 through 2010 (includes corresponding Graph/Chart) III-36
Table 27: Japanese 10-Year Perspective for Reagents in Biotechnology by Product Segment - Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein
Synthesis Reagents Markets for 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-37

4. Europe III-38

A. Market Analysis III-38
Biotechnology in Europe on an Expansion Spree III-38
Key Players III-38
Biomerieux (France) III-38
Roche Diagnostics (Switzerland) III-38
Product Launches III-39
Strategic Developments III-39
B. Market Analytics III-41
Table 28: European Recent Past, Current & Future Analysis for Reagents in Biotechnology by Geographic Region - France, Germany, Italy, UK, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-41
Table 29: European 10-Year Perspective for Reagents in Biotechnology by Product Segment - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, and Rest of Europe for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-41
Table 30: European Recent Past, Current & Future Analysis for Reagents in Biotechnology by Product Segment - Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-42
Table 31: European 10-Year Perspective for Reagents in Biotechnology by Product Segment - Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-43

4a. France III-44

Market Analysis III-44
Table 32: French Recent Past, Current & Future Analysis for Reagents in Biotechnology by Product Segment - Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-44
Table 33: French 10-Year Perspective for Reagents inBiotechnology by Product Segment - PercentageBreakdown of Dollar Sales for Cell/Tissue CultureReagents, DNA Sequencing/ Synthesis Reagents,Electrophoresis Reagents, Flow Cytometry Reagents,Immunoassay Reagents, Liquid ChromatographyReagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for Years2000, 2006 & 2010 (includes corresponding Graph/Chart) III-45

4b. Germany III-46

A. Market Analysis III-46
German Biotech Industry Review III-46
Outlook III-46
Strategic Development III-47
Key Player Review III-47
GE Healthcare/Amersham Plc III-47
B. Market Analytics III-48
Table 34: German Recent Past, Current & Future Analysis for Reagents in Biotechnology by Product Segment - Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-48
Table 35: German 10-Year Perspective for Reagents in Biotechnology by Product Segment - Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-49

4c. Italy III-50

Market Analysis III-50
Table 36: Italian Recent Past, Current & Future Analysis for Reagents in Biotechnology by Product Segment - Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-50
Table 37: Italian 10-Year Perspective for Reagents in Biotechnology by Product Segment - Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-51

4d. The United Kingdom III-52

A. Market Analysis III-52
Research Entities III-52
Commercial Activities III-52
Strategic Developments III-52
B. Market Analytics III-53
Table 38: UK Recent Past, Current & Future Analysis for Reagents in Biotechnology by Product Segment - Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through
2010 (includes corresponding Graph/Chart) III-53
Table 39: UK 10-Year Perspective for Reagents in Biotechnology by Product Segment - Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein
Synthesis Reagents Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-54

4e. Rest of Europe III-55

A. Market Analysis III-55
Medical Device Market in Spain III-55
Russian Clinical Diagnostic Equipment and
Supplies Market III-55
Major Reagent Producers III-55
Product Launches III-56
Strategic Developments III-56
B. Market Analytics III-57
Table 40: Rest of Europe Market for Reagents in Biotechnology - Recent Past, Current & Future Analysis by Product Segment for Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-57
Table 41: Rest of Europe 10-Year Perspective for Reagents in Biotechnology by Product Segment - Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein
ynthesis Reagents Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-58

5. Asia-Pacific III-59

A. Market Analysis III-59
Biotechnology- A Burgeoning Market III-59
Impact of IPR on Biotechnology Market III-59
Asia-Pacific - A Lucrative R&D Base III-59
Focus on Key Biotechnology Markets III-60
India III-60
China III-60
Korea III-61
Clinical Lab Products Market in Korea III-61
Product Launches III-61
Strategic Developments III-61
B. Market Analytics III-63
Table 42: Asia-Pacific Market for Reagents in Biotechnology Recent Past, Current & Future Analysis by Product Segment for Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-63
Table 43: Asia-Pacific 10-Year Perspective for Reagents in Biotechnology by Product Segment - Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-64

6. Latin America III-65

Market Analysis III-65
Table 44: Latin American Market for Reagents in Biotechnology - Recent Past, Current & Future Analysis by Product Segment for Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2010 (includes corresponding Graph/Chart) III-65
Table 45: Latin American 10-Year Perspective for Reagents in Biotechnology by Product Segment - Percentage Breakdown of Dollar Sales for Cell/Tissue Culture Reagents, DNA Sequencing/ Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents Markets for Years 2000, 2006 & 2010 (includes corresponding Graph/Chart) III-66

IV. COMPETITION

1. 454 Life Sciences (USA) IV-1
2. Abbott Diagnostics Division of Abbott Laboratories (USA) IV-2
3. Abcell Oy (Finland) IV-13
4. Abcys SA (France) IV-14
5. Accurate Chemical & Scientific Corporation (USA) IV-16
6. Adaltis, Inc. (Canada) IV-17
Adaltis Deutschland GmbH (Germany) IV-19
Adaltis Italia SpA (Italy) IV-19
7. Advanced Biotechnologies, Inc. (USA) IV-20
8. Advanced ChemTech, Inc. (USA) IV-23
9. AES Laboratoire (France) IV-24
10. Affibody AB (Sweden) IV-25
Table 46: Annual Sales Analysis: 2004-2005 (In SEK million) IV-25
11. Affinity BioReagents, Inc. (USA) IV-26
12. Agdia, Inc. (USA) IV-28
13. Agilent Technologies, Inc. (USA) IV-32
Table 47: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-34
Table 48: Annual Sales Analysis: 2004-2005 (In US$ million) IV-34
Table 49: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-34
Table 50: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-35
Table 51: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-35
14. AH Diagnostics AS (Denmark) IV-46
AH Diagnostics AB (Sweden) IV-46
15. Alba Bioscience (UK) IV-47
16. AlerCHEK, Inc. (USA) IV-47
17. Alltech Associates, Inc. (USA) IV-48
18. Alpha Diagnostic International, Inc. (USA) IV-56
19. Alpha Innotech Corporation (USA) IV-60
Table 52: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-60
Table 53: Annual Sales Analysis: 2004-2005 (In US$ million) IV-61
Table 54: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-61
Table 55: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-61
20. Altor BioScience Corporation (USA) IV-63
21. American Bioanalytical, Inc. (USA) IV-64
22. American Qualex (USA) IV-66
23. American Type Culture Collection (USA) IV-67
24. Amgen, Inc. (USA) IV-70
Table 56: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-71
Table 57: Half Yearly Sales Analysis by Segment: 2005-2006 (H1) (In US$ million) IV-71
Table 58: Annual Sales Analysis: 2004-2005 (In US$ million) IV-71
Table 59: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-71
Table 60: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-72
25. Amphotech Limited (USA) IV-75
26. Amresco, Inc. (USA) IV-77
27. Anachemia Chemicals, Inc. (USA) IV-78
28. Antigenix America, Inc. (USA) IV-80
29. Applichem GmbH (Germany) IV-84
30. Applied Biosystems (USA) IV-85
Table 61: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, March) (In US$ billion) IV-86
Table 62: Nine Months Sales Analysis by Segment: 2005-2006 (Nine Months Ended, March) (In US$ billion) IV-86
Table 63: Nine Months Sales Analysis by Product: 2005-2006 (Nine Months Ended, March) (In US$ billion) IV-86
Table 64: Nine Months Sales Analysis by Geographic Region: 2005-2006 (Nine Months Ended, March) (In US$ billion) IV-86
Table 65: Annual Sales Analysis: 2004-2005 (In US$ billion) IV-87Table 66: Annual Sales Analysis by Quarter: 2004-2005 (In US$ billion) IV-87
Table 67: Annual Sales Analysis by Segment: 2004-2005 (In US$ billion) IV-87
Table 68: Annual Sales Analysis by Product: 2004-2005 (In US$ billion) IV-87
Table 69: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ billion) IV-88
Ambion, Inc. (USA) IV-92
31. Argonaut Technologies, Inc (USA) IV-93
32. Australian Laboratory Services Pty., Ltd. (Australia) IV-94
33. Avanti Polar Lipids, Inc. (USA) IV-96
34. Axis-Shield PLC (UK) IV-98
Table 70: Annual Sales Analysis: 2004-2005 (In £ million) IV-98
Table 71: Annual Sales Analysis by Segment: 2004-2005 (In £ million) IV-99
35. Axordia Limited (UK) IV-100
36. Bachem AG (Switzerland) IV-102
Table 72: Half Yearly Sales Analysis: 2005-2006 (H1) (In CHF million) IV-102Table 73: Annual Sales Analysis: 2004-2005 (In CHF million) IV-103
Table 74: Annual Sales Analysis by Segment: 2004-2005 (In CHF million) IV-103
Table 75: Annual Sales Analysis by Geographic Region: 2004-2005 (In CHF million) IV-103
Bachem (UK) Ltd. (UK) IV-107
Bachem Biochemica GmbH (Germany) IV-107
37. Beckman Coulter, Inc. (USA) IV-108
Table 76: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-112
Table 77: Half Yearly Sales Analysis by Segment: 2005-2006 (H1) (In US$ million) IV-112
Table 78: Half Yearly Sales Analysis by Geographic Region: 2005-2006 (H1) (In US$ million) IV-112
Table 79: Annual Sales Analysis: 2004-2005 (In US$ million) IV-112
Table 80: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-112
Table 81: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-113
Beckman Coulter GmbH (USA) IV-116
Diagnostic Systems Laboratories, Inc. (USA) IV-118
Lumigen, Inc. (USA) IV-119
38. Becton, Dickinson & Company (USA) IV-120
Table 82: Nine Months Sales Analysis: 2005-2006
(Nine Months Ended, June) (In US$ million) IV-122
Table 83: Nine Months Sales Analysis by Quarter:
2005-2006 (Nine Months Ended, June) (In US$ million) IV-122
Table 84: Nine Months Sales Analysis by Segment: 2005-2006 (Nine Months Ended, June) (In US$ million) IV-122
Table 85: Nine Months Sales Analysis by Geographic Region: 2005-2006 (Nine Months Ended, June) (In US$ million) IV-122
Table 86: Annual Sales Analysis: 2004-2005 (In US$ million) IV-122
Table 87: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-123
Table 88: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-123
Table 89: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-123
BD Biosciences (USA) IV-128
BD Diagnostic Systems (USA) IV-144
BD Immunocytometry Systems (USA) IV-146
39. Biocare Medical LLC (USA) IV-147
40. Biocell Laboratories, Inc (USA) IV-148
41. Biochemical Diagnostics, Inc. (USA) IV-150
42. Biocientifica SA (Argentina) IV-154
43. Bioclone Australia Pty., Ltd (Australia) IV-155
44. BioFX Laboratories, Inc. (USA) IV-156
45. BioGenex Laboratories, Inc. (USA) IV-158
46. Biologos, Inc. (USA) IV-161
47. Biomar Diagnostic Systems GmbH (Germany) IV-162
48. Biomeda Corporation (USA) IV-163
49. Biomerieux SA (France) IV-169
Table 90: Half Yearly Sales Analysis: 2005-2006 (H1) (In € million) IV-170
Table 91: Half Yearly Sales Analysis by Segment: 005-2006 (H1) (In € million) IV-170
Table 92: Half Yearly Sales Analysis by Geographic Region: 2005-2006 (H1) (In € million) IV-171
Table 93: Annual Sales Analysis: 2004-2005 (In € million) IV-171
Table 94: Annual Sales Analysis by Segment: 2004-2005 (In € million) IV-171
Table 95: Annual Sales Analysis by Geographic Region: 2004-2005 (In € million) IV-171
Biomerieux, Inc. (USA) IV-176
Biomerieux Espana SA (Spain) IV-179
50. Biomidi (France) IV-180
51. Biomol GmbH (Germany) IV-181
Biomol Research Laboratories, Inc. (USA) IV-186
52. Bion Enterprises Limited (USA) IV-189
53. BioNova Cientifica SL (Spain) IV-189
54. Bio-Rad Laboratories, Inc. (USA) IV-190
Table 96: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-191
Table 97: Half Yearly Sales Analysis by Segment: 2005-2006 (H1) (In US$ million) IV-192
Table 98: Annual Sales Analysis: 2004-2005 (In US$ million) IV-192
Table 99: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-192
Table 100: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-192
Table 101: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-192
Bio-Rad Laboratories - Life Science Group Divison (USA) IV-202
Bio-Rad Laboratories (UK) Ltd. (UK) IV-203
55. Bioreba AG (Switzerland) IV-204
56. Biosearch Technologies, Inc. (USA) IV-205
57. Biospa Division (Italy) IV-210
58. BiosPacific, Inc. (USA) IV-210
59. Biosynth AG (Switzerland) IV-211
60. Biotech India (India) IV-212
61. Biotech-IgG AS (Denmark) IV-213
62. Biotecx Laboratories, Inc. (USA) IV-214
63. Biotest AG (Germany) IV-215
Biotest Diagnostics Corporation (USA) IV-216
Biotest (UK) Limited (UK) IV-218
64. Biotrend Chemikalien GmbH (Germany) IV-220
65. Biovalley SA (France) IV-223
66. BioVectra DCL (Canada) IV-225
67. Biozol Diagnostica Vertrieb GmbH (Germany) IV-226
68. Biozyme Laboratories Limited (UK) IV-228
69. Blue Heron Biotechnology, Inc. (USA) IV-229
70. Brand-Nu Laboratories (USA) IV-230
71. British Biocell International Limited (UK) IV-231
Table 102: Annual Sales Analysis: 2005-2006 (In £ billion) IV-231
Table 103: Annual Sales Analysis by Segment: 2005-2006: (In £ billion) IV-231
72. CalbaTech, Inc. (USA) IV-233
Table 104: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-234
Table 105: Annual Sales Analysis: 2004-2005 (In US$ million) IV-234
73. Cambio Limited (UK) IV-235
74. Cambrex Corporation (USA) IV-239
Table 106: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-241
Table 107: Half Yearly Sales Analysis by Quarter: 2005-2006 (H1) (In US$ million) IV-241
Table 108: Annual Sales Analysis: 2004-2005 (In US$ million) IV-241
Table 109: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-241
Cambrex Bio Science Rockland, Inc. (USA) IV-246
75. Cambridge Life Sciences PLC (UK) IV-247
76. Carl Roth GmbH & Co. (Germany) IV-248
77. Carlo Erba Reagenti Srl (Italy) IV-249
78. Cayman Chemical Co. (USA) IV-250
79. Cedarlane Laboratories Limited (Canada) IV-253
80. Celbio Srl (Italy) IV-253
81. Cell Sciences, Inc. (USA) IV-254
82. Celltech Group PLC (UK) IV-255
83. Chemicon International, Inc. (USA) IV-256
Chemicon Australia Pty., Ltd. (Australia) IV-260
84. Chromogenix Instrumentation Laboratory SpA (Italy) IV-262
85. Ciphergen Biosystems, Inc. (USA) IV-263
Table 110: First Quarter Sales Analysis: 2005-2006 (In US$ million) IV-264
Table 111: Annual Sales Analysis: 2004-2005 (In US$ million) IV-264
86. Consorta, Inc. (USA) IV-267
87. Continental Lab Products, Inc. (USA) IV-268
88. Cortex Biochem, Inc. (USA) IV-270
89. D&F Control Systems, Inc. (USA) IV-274
90. Dade Behring, Inc. (USA) IV-275
Table 112: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-276
Table 113: Half Yearly Sales Analysis by Quarter: 2005-2006 (H1) (In US$ million) IV-277
Table 114: Half Yearly Sales Analysis by Segment: 2005-2006 (H1) (In US$ million) IV-277
Table 115: Half Yearly Sales Analysis by Geographic Region: 2005-2006 (H1) (In US$ million) IV-277
Table 116: Annual Sales Analysis: 2004-2005 (In US$ million) IV-277
Table 117: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-277
Table 118: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-278
Table 119: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-278
91. Daiichi Pure Chemicals Co., Ltd. (Japan) IV-299
92. Dakocytomation Denmark A/S (Denmark) IV-300
Dakocytomation (USA) IV-302
Dakocytomation Ltd. (UK) IV-303
93. DCS Innovative Diagnostik Systeme (Germany) IV-306
94. Diagnostic Biosystems (USA) IV-307
95. Diagnostic Technology (Australia) IV-309
96. Diagnostix Limited (Canada) IV-310
97. DiaSorin SpA (Italy) IV-313
Diasorin, Inc. (USA) IV-314
98. Diatech Srl (Italy) IV-316
99. Dionex Corporation (USA) IV-317
Table 120: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, March) (In US$ million) IV-318
Table 121: Annual Sales Analysis: 2004-2005 (In US$ million) IV-318
100. Drew Scientific Group PLC (UK) IV-328
101. DRG Instruments GmbH (Germany) IV-329
102. Dyax Corporation (USA) IV-330
Table 122: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million) IV-331
Table 123: Annual Sales Analysis: 2004-2005 (In US$ million) IV-331
Table 124: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-331
103. EastCoast Bio, Inc. (USA) IV-333
104. Epicentre Biotechnologies (USA) IV-333
105. Epitome Biosystems (USA) IV-334
106. Epitomics, Inc. (USA) IV-335
107. Eppendorf (USA) IV-337
108. ESA Biosciences, Inc. (USA) IV-338
109. Exalpha Biologicals, Inc. (USA) IV-340
110. Exiqon A/S (Denmark) IV-341
111. E-Y Laboratories, Inc. (USA) IV-342
112. Fermentas, Inc. (USA) IV-343
113. Finnzymes Oy (Finland) IV-344
114. Fisher Biosciences (USA) IV-345
ABgene (UK) IV-346
115. Fitzgerald Industries International, Inc. (USA) IV-348
116. FMC Corporation (USA) IV-349
Table 125: First Quarter Sales Analysis: 2005-2006 (In US$ million) IV-351
Table 126: Annual Sales Analysis: 2004-2005 (In US$ million) IV-351
Table 127: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-352
Table 128: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-352
Table 129: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-352
117. Gallus Immunotech, Inc. (Canada) IV-356
118. GE Healthcare (USA) IV-358
119. Genaxis Biotechnology (France) IV-377
120. Genemed Biotechnologies, Inc. (USA) IV-378
121. General Biologicals, Inc. (Taiwan) IV-379
122. Genhunter Corporation (USA) IV-381
123. Geno Technology, Inc. (USA) IV-385
124. Genzyme Diagnostics (USA) IV-398
125. Glen Research Corporation (USA) IV-399
126. Goodwin Biotechnology, Inc. (USA) IV-403
127. GroPep Limited (Australia) IV-405
Table 130: Annual Sales Analysis: 2005-2006 (In A$ million) IV-407
Table 131: Annual Sales Analysis by Business Segment: 2005-2006 (In A$ million) IV-407
128. Guava Technologies, Inc. (USA) IV-409
129. Guildhay Ltd. (UK) IV-412
130. Helena Laboratories, Inc. (USA) IV-413
131. Histo-Line Laboratories (Italy) IV-415
132. Honeywell Burdick & Jackson (USA) IV-416
133. Hycult Biotechnology BV (The Netherlands) IV-418
134. Hytest Ltd. (Finland) IV-419
135. Ibex Technologies, Inc., (IBT) (Canada) IV-421
136. IBL Gesellschaft Fur Immunchemie Und Immunbiologie MBH (Germany) IV-422
137. IBT - Immunological & Biochemical Test systems GmbH (Germany) IV-423
138. Imgenex Corporation (USA) IV-424
139. Illumina, Inc. (USA) IV-426
Table 132: Annual Sales Analysis: 2005-2006 (In US$ million) IV-426
Table 133: Annual Sales Analysis by Quarter: 2005-2006 (In US$ million) IV-427
Table 134: Annual Sales Analysis by Geographic Region: 2005-2006 (In US$ million) IV-427
140. IMMCO Diagnostics (USA) IV-432
141. Immucor, Inc. (USA) IV-433
Table 135: First Quarter Sales Analysis: 2006-2007 (In US$ million) IV-433
Table 136: First Quarter Sales Analysis by Geographic: 2006-2007 (In US$ million) IV-434
Table 137: Annual Sales Analysis: 2004-2006 (In US$ million) IV-434
Table 138: Annual Sales Analysis by Quarter: 2005-2006 (In US$ million) IV-434
Table 139: Annual Sales Analysis by Geographic Region: 2005-2006 (In US$ million) IV-435
Table 140: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-435
Table 141: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-435
142. Immunicon Corporation (USA) IV-438
Table 142: Annual Sales Analysis: 2004-2005 (In US$ million) IV-438
Table 143: Annual Sales Analysis by Geographic
Region: 2004-2005 (In US$ million) IV-439
143. Immunochemistry Technologies LLC (USA) IV-441
144. Immunolab GmbH (Germany) IV-441
145. Immunos (USA) IV-442
146. Inalco Group (Italy) IV-445
147. Inamco International Corporation (USA) IV-447
148. Inbios Srl (Italy) IV-448
149. Incell Corporation LLC (USA) IV-449
150. Incyte Genomics (USA) IV-451
151. Inverness Medical Innovations, Inc. (USA) IV-452
Table 144: First Quarter Sales Analysis: 2005-2006 (In US$ million) IV-452
Table 145: Annual Sales Analysis: 2004-2005 (In US$ million) IV-453
Table 146: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-453
Table 147: Annual Sales Analysis by Business Segment: 2004-2005 (In US$ million) IV-453
Table 148: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-453
152. Invitrogen Corporation (USA) IV-455
Table 149: First Quarter Sales Analysis: 2005-2006 (In US$ million) IV-456
Table 150: First Quarter Sales Analysis by Segment: 2005-2006 (In US$ million) IV-456
Table 151: Annual Sales Analysis: 2004-2005 (In US$ million) IV-456
Table 152: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-456
Table 153: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-457
Caltag Laboratories, Inc. (USA) IV-463
153. Jackson Immunoresearch Laboratories, Inc. (USA) IV-465
154. Johnson & Johnson (USA) IV-466
Table 154: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million) IV-468
Table 155: Nine Months Sales Analysis by Segment:
2005-2006 (Nine Months Ended, September) (In US$ million) IV-468
Table 156: Nine Months Sales Analysis by Geographic Region: 2005-2006 (Nine Months Ended, September) (In US$ million) IV-468
Table 157: Annual Sales Analysis: 2004-2005 (In US$ million) IV-468
Table 158: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-469
Table 159: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-469
Ortho-Clinical Diagnostics (USA) IV-477
155. Kamiya Biomedical Company (USA) IV-480
156. Kamtek, Inc. (USA) IV-482
157. Kem-EN-Tec Diagnostics A/S (Denmark) IV-483
158. Kent Labs, Inc. (USA) IV-484
159. Kirkegaard & Perry Laboratories, Inc. (USA) IV-485
160. KMI Diagnostics, Inc. (USA) IV-486
161. Koma Biotech, Inc. (Korea) IV-486
162. Kreatech Diagnostic/Kreatech Biotechnology BV (The Netherlands) IV-487
163. Laboratories Eurobio SA (France) IV-489
164. Labscan Limited (Ireland) IV-489
165. Lampire Biological Laboratories (USA) IV-490
166. Lennox Laboratory Supplies Ltd. (Ireland) IV-491
167. LI-COR Biosciences (USA) IV-492
168. Loxo GmbH - Immunbiologie-Biochemie Products
Und Systems (Germany) IV-494
169. MacConnell Research Corporation (USA) IV-494
170. Maine Biotechnology Services, Inc. (USA) IV-495
171. Mallinckrodt Baker, Inc. (USA) IV-496
172. Marker Gene Technologies, Inc. (USA) IV-498
173. Mascia Brunelli SpA (Italy) IV-499
174. Matritech, Inc. (USA) IV-500
Table 160: First Quarter Sales Analysis: 2005-2006 (In US$ million) IV-501
Table 161: Annual Sales Analysis: 2004-2005 (In US$ million) IV-501
175. Matrix Technologies Corporation (USA) IV-502
176. MD Biosciences, Inc. (USA) IV-504
177. Medarex, Inc. (USA) IV-505
Table 162: First Quarter Sales Analysis: 2005-2006 (In US$ million) IV-506
Table 163: Annual Sales Analysis: 2004-2005 (In US$ million) IV-506
Table 164: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-506
178. Mediatech, Inc. (USA) IV-509
179. Medical Chemical Corporation (USA) IV-510
180. Medicorp, Inc. (Canada) IV-511
181. Medi-Cult A/S (Denmark) IV-512
182. Medix Biochemica OY AB (Finland) IV-514
183. Merck KgaA (Germany) IV-515
Table 165: Annual Sales Analysis: 2004-2005 (In € million) IV-517
Table 166: Annual Sales Analysis Segment: 2004-2005 (In € million) IV-517
EMD Biosciences, Inc. (USA) IV-521
Merck Ltd. (Taiwan) IV-526
184. Meridian Bioscience, Inc. (USA) IV-527
Table 167: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, June) (In US$ million) IV-529
Table 168: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, June) (In US$ million) IV-529
Table 169: Annual Sales Analysis: 2004-2005 (In US$ million) IV-529
Table 170: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-529
Table 171: Annual Sales Analysis by Business Segment: 2004-2005 (In US $ million) IV-530
Biodesign International (USA) IV-532
OEM Concepts, Inc. (USA) IV-534
185. Microbix Biosystems, Inc. (Canada) IV-535
Table 172: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, June) (In US$ million) IV-535
186. Microzone Limited (UK) IV-537
187. Midland Bioproducts Corporation (MBC) (USA) IV-538
188. Mikro+Polo (Slovenia) IV-539
189. Millipore Corporation (USA) IV-540
Table 173: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-541
Table 174: Half Yearly Sales Analysis by Business Segment: 2005-2006 (H1) (In US$ million) IV-541
Table 175: Half Yearly Sales Analysis by Geographic Region: 2005-2006 (H1) (In US$ million) IV-541
Table 176: Annual Sales Analysis: 2004-2005 (In US$ million) IV-541
Table 177: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-541
Table 178: Annual Sales Analysis by Business Segment: 2004-2005 (In US$ million) IV-542
Table 179: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-542
Millipore GesmbH (Austria) IV-547
Millipore SA NV (Belgium) IV-548
190. Miltenyi Biotec GmbH (Germany) IV-549
191. Mobitec GmbH (Germany) IV-550
192. Molecular Biosciences, Inc. (USA) IV-551
193. Molecular Devices Corporation (USA) IV-552
Table 180: First Quarter Sales Analysis:
2005-2006 (In US$ million) IV-553
Table 181: Annual Sales Analysis: 2004-2005 (In US$ million) IV-553
Table 182: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-553
Table 183: Annual Sales Analysis by Product: 2004-2005 (In US$ million) IV-553
Table 184: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-554
Molecular Devices GmbH (Germany) IV-557
194. Molecular Research Center, Inc. (USA) IV-558
195. Monobind, Inc. (USA) IV-560
196. Moss, Inc. (USA) IV-560
197. MP Biomedicals (USA) IV-561
198. Mubio Products BV (The Netherlands) IV-562
199. Nanogen, Inc. (USA) IV-563
Table 185: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-564
Table 186: Annual Sales Analysis: 2004-2005 (In US$ million) IV-564
200. Nanoprobes, Inc. (USA) IV-569
201. National Diagnostics, Inc. (USA) IV-570
202. Neogen Corporation (USA) IV-571
Table 187: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, February) (In US$ million) IV-572
Table 188: Nine Months Sales Analysis by Quarter: 2005-2006 (Nine Months Ended, February) (In US$ million) IV-572
Table 189: Nine Months Sales Analysis by Segment: 2005-2006 (Nine Months Ended, February) (In US$ million) IV-572
Table 190: Annual Sales Analysis: 2004-2005 (In US$ million) IV-573
Table 191: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-573
Table 192: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-573
Table 193: Annual Sales Analysis by Product: 2004-2005 (In US$ million) IV-573
203. New England Biolabs, Inc. (USA) IV-576
New England Biolabs (UK) Ltd. (UK) IV-578
204. Nordic Immunological Laboratories (The Netherlands) IV-579
205. Novachem Pty., Ltd. (Australia) IV-579
206. Novocastra Laboratories Ltd. (UK) IV-580
207. Novozymes, Inc. (USA) IV-580
208. Olympus Life And Material Science Europa GmbH (Germany) IV-581
209. Onbio, Inc. (Canada) IV-582
210. One Lambda, Inc. (USA) IV-582
211. Orasure Technologies, Inc. (USA) IV-583
Table 194: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-584
Table 195: Half Yearly Sales Analysis by Segment: 2005-2006 (H1) (In US$ million) IV-584
Table 196: Half Yearly Sales Analysis by Geographic Region: 2005-2006 (H1) (In US$ million) IV-584
Table 197: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-584
Table 198: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-585
Table 199: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-585
212. Orpegen Pharma GmbH (Germany) IV-589
213. Oxford Biomedical Research, Inc. (USA) IV-590
214. OXIS International, Inc. (USA) IV-591
Table 200: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-591
Table 201: Annual Sales Analysis: 2004-2005 (In US$ million) IV-592
215. P.J. Cobert Associates, Inc. (USA) IV-592
216. Panbio Ltd. (Australia) IV-593
Table 202: Annual Sales Analysis: 2005-2006 (In A$ million) IV-593
Table 203: Annul Sales Analysis by Geographic Region: 2005-2006 (In A$ million) IV-593
Panbio, Inc. (USA) IV-594
217. Panomics, Inc. (USA) IV-595
218. PBL Biomedical Laboratories (USA) IV-596
219. Peprotech, Inc. (USA) IV-596
220. PerkinElmer, Inc. (USA) IV-597
Table 204: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-598
Table 205: Half Yearly Sales Analysis by Segment: 2005-2006 (H1) (In US$ million) IV-598
Table 206: Annual Sales Analysis: 2004-2005 (In US$ million) IV-599
Table 207: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million): IV-599
Table 208: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-599
Table 209: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-599
Perkinelmer Life And Analytical Sciences, Inc. (USA) IV-609
221. Pickering Laboratories, Inc. (USA) IV-610
222. Pierce Biotechnology, Inc. (USA) IV-610
223. Pointe Scientific, Inc. (USA) IV-611
224. Prime Synthesis, Inc. (USA) IV-612
225. Primm Labs, Inc. (USA) IV-614
226. Progen Biotechnik GmbH (Germany) IV-615
227. Promega Corporation (USA) IV-617
Promega Biosciences, Inc. (USA) IV-618
Promega Corporation (Australia) IV-619
Promega UK Limited (UK) IV-619
228. Promocell GmbH (Germany) IV-622
229. Protein Technologies, Inc. (USA) IV-624
230. Protoprobe, Inc. (USA) IV-624
231. Protos Immunoresearch (USA) IV-625
232. Prozyme, Inc. (USA) IV-626
233. Qbiogene, Inc. (USA) IV-627
234. Qed Bioscience, Inc. (USA) IV-628
235. Qiagen NV (The Netherlands) IV-630
Table 210: Annual Sales Analysis: 2004-2005 (In US$ million) IV-630
Table 211: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-631
Qiagen, Inc. (USA) IV-634
QIAGEN GmbH (Germany) IV-634
236. Quality Biological, Inc. (USA) IV-636
237. R. Shadel, Inc. (USA) IV-636
238. Ramco Laboratories, Inc. (USA) IV-637
239. Reagecon Diagnostics Ltd. (Ireland) IV-637
240. ReaMetrix India Pvt., Ltd. (India) IV-638
241. Regis Technologies, Inc. (USA) IV-639
242. Repligen Corporation (USA) IV-640
Table 212: Annual Sales Analysis: 2005-2006 (In US$ million) IV-640
243. Research Organics, Inc. (USA) IV-641
244. Retrogen, Inc. (USA) IV-641
245. Ricca Chemical Company (USA) IV-642
246. Roche Diagnostics (Schweiz) AG (Switzerland) IV-644
Roche Diagnostics Corporation (USA) IV-647
247. Rockland Immunochemicals, Inc. (USA) IV-650
248. Santa Cruz Biotechnology, Inc. (USA) IV-650
249. Sanyo Chemical Industries Ltd. (Japan) IV-651
250. Scantibodies Laboratory, Inc. (USA) IV-660
251. Scharlau Chemie SA (Spain) IV-662
252. Scipac Ltd. (UK) IV-663
253. Scripps Laboratories, Inc. (USA) IV-664
254. Scytek Laboratories, Inc. (USA) IV-666
255. Sebia (France) IV-668
Sebia Electrophoresis (USA) IV-668
256. Seracare Life Sciences, Inc. (USA) IV-669
257. Seradyn, Inc. (USA) IV-671
258. Serotec Ltd. (UK) IV-672
259. Serva Electrophoresis GmbH (Germany) IV-673
260. Severn Biotech Limited (UK) IV-674
261. SFRI Laboratoire (France) IV-675
262. Shimadzu Corporation (Japan) IV-676
Table 213: Annual Sales Analysis: 2004-2005 (In ¥ million) IV-677
Table 214: Annual Sales Analysis by Segment: 2004-2005 (In ¥ million) IV-678
Table 215: Annual Sales Analysis by Geographic Region: 2004-2005 (In ¥ million) IV-678
263. Sigma-Aldrich Corporation (USA) IV-681
Table 216: First Quarter Sales Analysis: 2005-2006 (In US$ million) IV-682
Table 217: First Quarter Sales Analysis by Segment: 2005-2006 (In US$ million) IV-682
Table 218: First Quarter Sales Analysis by Geographic Region: 2005-2006 (In US$ million) IV-682
Table 219: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-682
Table 220: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-682
Table 221: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-683
Safc Biosciences (USA) IV-689
SAFC Supply Solutions (USA) IV-691
264. Skybio Limited (UK) IV-693
265. Solulink, Inc. (USA) IV-695
266. Southernbiotech (USA) IV-696
267. Spectral Diagnostics, Inc. (Canada) IV-697
Table 222: First Quarter Sales Analysis: 2006-2007 (In Can$ million) IV-697
Table 223: Annual Sales Analysis: 2005-2006 (In Can$ million) IV-697
Table 224: Annual Sales Analysis by Quarter: 2005-2006 (In Can$ million) IV-698
Table 225: Annual Sales Analysis by Geographic Region: 2005-2006 (In Can$ million) IV-698
268. Spectrum Laboratory Products, Inc. (USA) IV-700
269. Stabiligen (France) IV-701
270. Sterogene Bioseparations, Inc. (USA) IV-701
271. Stratagene, Inc. (USA) IV-702
Table 226: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-703
Table 227: Half Yearly Sales Analysis by Quarter: 2005-2006 (H1) (In US$ million) IV-704
Table 228: Annual Sales Analysis: 2004-2005 (In US$ million) IV-704
Table 229: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-704
Table 230: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-704
Table 231: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-704
272. Strategic Diagnostics, Inc. (USA) IV-707
Table 232: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-707
Table 233: Annual Sales Analysis: 2004-2005 (In US$ million) IV-708
Table 234: Annual Sales Analysis by Product: 2004-2005 (In US$ million) IV-708
Table 235: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-708
Strategic Biosolutions (USA) IV-713
273. Surmodics, Inc. (USA) IV-714
Table 236: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-714
Table 237: Half Yearly Sales Analysis by Quarter: 2005-2006 (H1) (In US$ million) IV-715
Table 238: Half Yearly Sales Analysis by Segment: 2005-2006 (H1) (In US$ million) IV-715
Table 239: Annual Sales Analysis: 2004-2005 (In US$ million) IV-715
Table 240: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-715
Table 241: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-715
274. Takara Bio, Inc. (Japan) IV-718
Table 242: Annual Sales Analysis: 2004-2005 (In ¥ billion) IV-718
Clontech Laboratories, Inc. (USA) IV-720
Takara Biotechnology (Japan) IV-722
275. Techne Corporation (USA) IV-723
Table 243: First Quarter Sales Analysis: 2006-2007 (In US$ million) IV-724
Table 244: First Quarter Sales Analysis by Business Segment: 2006-2007 (In US$ million) IV-724
Table 245: Annual Sales Analysis: 2004-2006 (In US$ million) IV-724
Table 246: Annual Sales Analysis by Quarter: 2005-2006 (In US$ million) IV-725
Table 247: Annual Sales Analysis by Business Segment: 2005-2006 (In US$ million) IV-725
Table 248: Annual Sales Analysis by Geographic Region: 2005-2006 (In US$ million) IV-725
Table 249: Annual Sales Analysis by Business Segment: 2004-2005 (In US$ million) IV-725
Table 250: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-725
R&D Systems, Inc. (USA) IV-726
276. Tema Ricerca (Italy) IV-727
277. Tepnel Life Sciences PLC (UK) IV-728
Table 251: Half Yearly Sales Analysis: 2005-2006 (H1) (In £ million) IV-728
Table 252: Half Yearly Sales Analysis by Business Segment: 2005-2006 (H1) (In £ million) IV-728
Table 253: Half Yearly Sales Analysis by Geographic Region: 2005-2006 (H1) (In £ million) IV-728
Table 254: Annual Sales Analysis: 2004-2005 (In £ million) IV-729
Table 255: Annual Sales Analysis by Business Segment: 2004-2005 (In £ million) IV-729
Table 256: Annual Sales Analysis by Geographic Region: 2004-2005 (In £ million) IV-729
278. The Binding Site, Inc. (USA) IV-731
The Binding Site Ltd. (UK) IV-731
279. The Midland Certified Reagent Company (USA) IV-734
280. Thermo Fisher Scientific, Inc. (USA) IV-735
Table 257: Annual Sales Analysis: 2004-2005 (In US$ million) IV-736
Hyclone Laboratories, Inc. (USA) IV-739
281. TNB Laboratories, Inc. (Canada) IV-741
282. Tosoh Corporation (Japan) IV-742
Table 258: First Quarter Sales Analysis: 2005-2006 (In ¥ billion) IV-744
Table 259: Annual Sales Analysis: 2004-2005 (In ¥ billion) IV-744
Table 260: Annual Sales Analysis by Segment: 2004-2005 (In ¥ billion) IV-744
Table 261: Annual Sales Analysis by Geographic Region: 2004-2005 (In ¥ billion) IV-744
Tosoh Bioscience, Inc. (USA) IV-747
Tosoh Bioscience GmbH (Germany) IV-748
283. Transgenomic, Inc. (USA) IV-749
Table 262: Half Yearly Sales Analysis: 2005-2006 (H1) (In US$ million) IV-750
Table 263: Half Yearly Sales Analysis by Business Segment: 2005-2006 (H1) (In US$ million) IV-750
Table 264: Half Yearly Sales Analysis by Geographic Region: 2005-2006 (H1) (In US$ million) IV-750
Table 265: Annual Sales Analysis: 2004-2005 (In US$ million) IV-750
Table 266: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-751
Table 267: Annual Sales Analysis by Business Segment: 2004-2005 (In US$ million) IV-751
Table 268: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-751
284. Trevigen, Inc. (USA) IV-753
285. Trinity Biotech PLC (Ireland) IV-754
Table 269: First Quarter Sales Analysis: 2005-2006 (In US$ million) IV-755
Table 270: First Quarter Sales Analysis by Product: 2005-2006 (In US$ million) IV-755
Table 271: First Quarter Sales Analysis by Geographic Region: 2005-2006 (In US$ million) IV-755
Table 272: Annual Sales Analysis: 2004-2005 (In US$ million) IV-756
Table 273: Annual Sales Analysis by Product: 2004-2005 (In US$ million) IV-756
Table 274: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-756
286. Tripath Imaging, Inc. (USA) IV-759
Table 275: Nine Months Sales Analysis: 2005-2006 (Nine Months Ended, September) (In US$ million) IV-759
Table 276: Nine Months Sales Analysis by Business Segment: 2005-2006 (Nine Months Ended, September) (In US$ million) IV-760
Table 277: Nine Months Sales Analysis by Geographic Region: 2005-2006 (Nine Months Ended, September) (In US$ million) IV-760
Table 278: Annual Sales Analysis: 2004-2005 (In US$ million) IV-760
Table 279: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-760
Table 280: Annual Sales Analysis by Business Segment: 2004-2005 (In US$ million) IV-760
Table 281: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-760
287. U.S. Genomics, Inc. (USA) IV-761
288. United Chemical Technologies, Inc. (USA) IV-763
289. Vector Laboratories, Inc. (USA) IV-764
290. Vector-Best (Russia) IV-765
291. Virostat, Inc. (USA) IV-766
292. VMRD, Inc. (USA) IV-767
293. VWR International, Inc. (USA) IV-768
Table 282: First Quarter Sales Analysis: 2005-2006 (In US$ million) IV-769
Table 283: First Quarter Sales Analysis by Segment: 2005-2006 (In US$ million) IV-769
Table 284: Annual Sales Analysis: 2004-2005 (In US$ million) IV-769
Table 285: Annual Sales Analysis by Segment: 2004-2005 (In US$ million) IV-770
294. Wako Pure Chemical Industries Ltd. (Japan) IV-773
Wako Chemicals USA, Inc. (USA) IV-774
295. Waters Corporation (USA) IV-775
Table 286: Annual Sales Analysis: 2004-2005 (In US$ million) IV-776
Table 287: Annual Sales Analysis by Quarter: 2004-2005 (In US$ million) IV-776
Table 288: Annual Sales Analysis by Geographic Region: 2004-2005 (In US$ million) IV-777
296. Zenyth Therapeutics Limited (Australia) IV-784
Table 289: Annual Sales Analysis: 2004-2005 (In A$ million) IV-784
297. Zeptometrix Corporation (USA) IV-786
298. Zeus Scientific, Inc. (USA) IV-787

バイオテクノロジー試薬とサプライの世界市場－戦略分析と将来予測－

Reagents & Supplies in Biotechnology

Abstract

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. EXECUTIVE SUMMARY

1. Outlook II-1

2. Market Dynamics II-2

3. Biotechnology - Industry Overview II-4

4. Product Overview II-7

5. Product Innovations/Introductions II-11

6. Recent Industry Activity II-23

7. Focus on Select Players Worldwide II-42

8. Global Market Perspective II-47

III. MARKET

1. United States III-1

2. Canada III-29

3. Japan III-32

4. Europe III-38

4a. France III-44

4b. Germany III-46

4c. Italy III-50

4d. The United Kingdom III-52

4e. Rest of Europe III-55

5. Asia-Pacific III-59

6. Latin America III-65

IV. COMPETITION